These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2493738)

  • 1. Abnormalities of arachidonate metabolism in experimental ciclosporin nephrotoxicity.
    Benigni A; Perico N; Remuzzi G
    Am J Nephrol; 1989; 9 Suppl 1():72-7. PubMed ID: 2493738
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased renal production of cytochrome P450-dependent metabolites of arachidonic acid in cyclosporine-induced nephrotoxicity.
    Sacerdoti D; Borsato M; Rigotti P; Amodio P; Angeli P; Ferraresso M; Plebani M; Gatta A
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():689-92. PubMed ID: 1825398
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental cyclosporine A nephrotoxicity: an international workshop. April 24-26, 1985, Basle.
    Clin Nephrol; 1986; 25 Suppl 1():S1-210. PubMed ID: 3708919
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of animal sex on experimental ciclosporin nephrotoxicity.
    Ross N; English J; Bennett WM
    Nephron; 1988; 48(1):58-60. PubMed ID: 3340255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasodilatory prostaglandins and cyclosporin nephrotoxicity.
    Neild GH
    Prostaglandins Leukot Essent Fatty Acids; 1988; 33(3):207-12. PubMed ID: 3070570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine nephrotoxicity in conscious sheep.
    Friedman AL; Kahng KU; Monaco DO; Rosen BD; Wait RB
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):595-602. PubMed ID: 3388503
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of lithium clearance measurements to assess renal tubular function in experimental and clinical cyclosporine nephrotoxicity.
    Whiting PH; Propper DJ; Simpson JG; McKay J; Jones MC; Catto GR
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):675-80. PubMed ID: 3388506
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic ciclosporin nephrotoxicity: a rabbit model.
    Thliveris JA; Yatscoff RW; Lukowski MP; Copeland KR; Jeffery JR; Murphy GF
    Nephron; 1991; 57(4):470-6. PubMed ID: 2046831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fish oil vehicle for cyclosporine lowers renal thromboxanes and reduces experimental nephrotoxicity.
    Elzinga L; Kelley VE; Houghton DC; Bennett WM
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1403-6. PubMed ID: 3824502
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental cyclosporine nephrotoxicity in the rat: effect of biliary ligation and cannulation.
    Heys SD; Duncan JI; Whiting PH
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):845-9. PubMed ID: 3388518
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcium antagonist prevents nephrotoxicity.
    Br J Hosp Med; 1988 Jul; 40(1):78. PubMed ID: 3167298
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of cyclosporine-associated nephrotoxicity by K-MAP.
    Teraoka S; Sanaka T; Sato H; Fuchinoue S; Honda H; Kawai T; Nakajima I; Tojinbara T; Fujita S; Funakoshi Y
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):179-82. PubMed ID: 3279608
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine nephrotoxicity: studies in laboratory animals.
    Sullivan BA; Hak LJ; Finn WF
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):145-54. PubMed ID: 3895655
    [No Abstract]   [Full Text] [Related]  

  • 14. Alterations of renal arachidonate metabolism in chronic glomerular disease.
    Patrono C; Ciabattoni G; Simonetti BM; Pierucci A
    Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():199-204. PubMed ID: 2949549
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative pathophysiology and histopathology of cyclosporine nephrotoxicity.
    Dieperink H; Starklint H; Kemp E; Leyssac PP
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):785-91. PubMed ID: 3291315
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine nephrotoxicity: a workshop to discuss mechanisms, diagnosis, and treatment.
    Humes HD; Coffman T; Halderman H; Mihatsch M; Henry M; Porter GA
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):833-40. PubMed ID: 3291323
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental cyclosporine nephrotoxicity: risk of concomitant chemotherapy.
    Ryffel B; Müller AM; Mihatsch MJ
    Clin Nephrol; 1986; 25 Suppl 1():S121-5. PubMed ID: 3708922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of cyclosporine-associated arteriolopathy by p-aminobenzoic acid-N-D-mannoside sodium salt (K-MAP) in spontaneous hypertensive rats.
    Teraoka S; Yamaguchi Y; Fujita S; Tojinbara S; Tanabe K; Fujikawa H; Suga H; Hayashi T; Nakajima I; Nakagawa Y
    Transplant Proc; 1990 Aug; 22(4):1717-9. PubMed ID: 2389441
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of acute cyclosporine A nephrotoxicity by a thromboxane synthetase inhibitor.
    Smeesters C; Chaland P; Giroux L; Moutquin JM; Etienne P; Douglas F; Corman J; St-Louis G; Daloze P
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):663-9. PubMed ID: 3163209
    [No Abstract]   [Full Text] [Related]  

  • 20. Abnormalities in arachidonic acid metabolites in nephrotoxic glomerular injury.
    Zoja C; Perico N; Remuzzi G
    Toxicol Lett; 1989 Mar; 46(1-3):65-75. PubMed ID: 2495584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.